Elastrography Lowers Redundant Breast Biopsies

According to an in-progress study presented during the yearly congregation of the Radiological Society of North America (RSNA) showed that elastography is an effectual, expedient system that when included to breast ultrasound aids in detection of cancerous breast lesions from benign outcomes.

When the outcome of mammography gives dubious findings, doctors mostly employ ultrasound to attain added information. On the other hand ultrasound has the possibility to lead to additional biopsies due to its comparatively squat specificity or incapability to precisely differentiate cancerous lesions from benign lesions. According to the American Cancer Society about eighty percent of breast lesions that underwent biopsies turned out to be benign in nature.

Stamatia V. Destounis, M.D., the lead author of the study and diagnostic radiologist from Elizabeth Wende Breast Care, a huge community based breast imaging center, Rochester, New York, stated that there is huge room for enhancing specificity using ultrasound and elastography could assist in doing that. It could be an easy means of eliminating needle biopsy for something that is possibly benign in nature.

Elastography enhances the specificity of ultrasound by employing conservative ultrasound imaging for measurement of the compressibility and mechanical properties of a lesion. As cancerous tumours have a tendency be firmer as compared to the adjacent normal tissue or cysts, an increasingly compressible lesion appearing on elastography has lesser likelihood of being malignant.

Dr. Destounis explicated that it was possible to conduct elastography at the analogous time as the handheld ultrasound device and viewing the pictures on a split screen, with the 2-D ultrasound imagery on the left and the imagery of the elastography on the right.

During the course of the in-progress study, 179 patients went through breast ultrasound and elastography. The research team acquired 184 elastograms and conducted biopsies on all the firm lesions. From the 134 biopsies, 56 showed cancer. Elastography accurately spotted 98% of the lesions which had malignant discoveries on biopsy, and 82% of lesions emerged to be benign. Elastography was additionally more precise as compared to ultrasound to gauge the size of the lesions.

Dr. Destounis stated that ultrasound could miscalculate the actual size of the lesions, as it solely views the true mass and not the neighbouring variations the mass could be causing.

According to the American Cancer Society that provided breast cancer facts during the year 2009, there would be an approximate 1,92, 370 newly surfaced cases of invasive breast cancer in women in the United States, alongside nearly 62,280 newly evolved cases of ductal carcinoma in situ (DCIS)which is a breast cancer type of an early non-invasive form.

Additionally during the RSNA 2009, Dr. Smitha Putturaya, M.D., F.R.C.R., presented findings derived from a partial, seven-year lasting study done on breast elastography carried out at the Charing Cross Hospital Breast Unit, London, U.K., Dr. Putturaya and associates discovered that on employing elastography as an add-on to regular breast ultrasound securely lowered the number of biopsies of benign lesions and proffers the probability of mapping tumours more accurately.

Popularity: 8% [?]